Stock Screener App

Frei -

Installieren

Medical Distribution

673.82

1.61% 10.65

Mckesson Corporation (MCK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Mckesson Corporation Aktie (MCK) Neueste Nachrichten

Synergy CHC Corp Reports Second Quarter 2025 Financial Results and its Tenth Consecutive Quarter of Profitability - GlobeNewswire Inc.

Can McKesson’s (MCK) Lower Earnings Shift Its Capital Allocation Priorities? - simplywall.st

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know - MSN

Wells Fargo Maintains McKesson(MCK.US) With Hold Rating, Raises Target Price to $772 - 富途牛牛

Pharmacy Profiles to provide credential verification services for McKesson's Health Mart pharmacies - Drug Store News

Saudi Arabia Teleradiology Market Trends and Company Analysis Report 2025-2033 Featuring FUJIFILM, Koninklijke Philips, General Electric, Oracle, Siemens, GE, McKesson - Yahoo Finance

Wells Fargo Maintains McKesson (MCK) with Raised Price Target to $772 | MCK Stock News - GuruFocus

McKesson price target raised to $772 from $766 at Wells Fargo - TipRanks

Wells Fargo Adjusts Price Target on McKesson to $772 From $766, Maintains Equalweight Rating - MarketScreener

The Top 5 Analyst Questions From McKesson’s Q2 Earnings Call - Yahoo Finance

Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies - The Globe and Mail

J.P. Morgan Keeps Their Buy Rating on McKesson (MCK) - The Globe and Mail

How McKesson’s (MCK) Earnings Beat, Dividend Hike, and Spin-Off Plans Have Changed Its Investment Story - simplywall.st

Published on: 2025-08-09 00:46:56 - Newser

Published on: 2025-08-08 22:45:07 - Newser

McKesson Climbs 0.80% Despite 99th-Ranked Trading Volume as Institutional Confidence and Dividend Hike Fuel Long-Term Optimism - AInvest

Deutsche Bank Reaffirms Their Buy Rating on McKesson (MCK) - The Globe and Mail

Mizuho Securities Sticks to Their Hold Rating for McKesson (MCK) - The Globe and Mail

Here's Why McKesson (MCK) is a Strong Value Stock - Yahoo Finance

Pharmaceutical Packaging Market Trends and Company Analysis - GlobeNewswire

Pharmaceutical Packaging Market Trends and Company Analysis Report 2025-2033 Featuring Amcor, 3M, Schott, WestRock, Berry Global, McKesson, AptarGroup, Klockner Pentaplast, CCL, FlexiTuff - Yahoo Finance

Citi Sticks to Its Buy Rating for McKesson (MCK) - The Globe and Mail

McKesson’s Strong Long-Term Growth Potential Justifies Buy Rating Despite Limited Immediate Upside - TipRanks

McKesson First Quarter 2026 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Candlestick signals on McKesson Corporation stock todayBreakout Watcher with Entry and Exit Alerts - Newser

Stock Analysis | McKesson OutlookTechnical Weakness and Mixed Analyst Signals - AInvest

McKesson’s Earnings Call Highlights Strong Growth and Strategic Moves - TipRanks

McKesson Corp. stock underperforms Thursday when compared to competitors - MSN

Relative Strength Alert For McKesson - Nasdaq

Deutsche Bank Adjusts Price Target on McKesson to $775 From $740, Maintains Buy Rating - MarketScreener

McKesson Corporation (NYSE:MCK) Q1 2026 Earnings Call Transcript - Insider Monkey

MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View - Yahoo Finance

McKesson Corp. Exceeds Expectations with Strong Q1 EarningsNews and Statistics - IndexBox

McKesson Increases Profit Forecast Due to Specialty Medicines DemandNews and Statistics - IndexBox

McKesson Achieves 23.4% Revenue Growth in Q2 CY2025News and Statistics - IndexBox

McKesson: Fiscal Q1 Earnings Snapshot - New Haven Register

Earnings call transcript: McKesson’s Q1 2026 results exceed forecasts, stock dips - Investing.com Australia

McKesson Lifts Forecast As Specialty Medicine Demand Grows - Finimize

McKesson Corporation Reports Strong Q1 2026 Results - TipRanks

Decoding McKesson Corp (MCK): A Strategic SWOT Insight - GuruFocus

McKesson (MCK) Q1 2026 Earnings Call Transcript - Fortune

McKesson’s Strong Performance and Strategic Moves Earn a Buy Rating from Charles Rhyee - TipRanks

McKesson 0.81% Stock Slide Contrasts $97.8B Revenue Surge and Strategic Acquisitions as Trading Volume Ranks 105th - AInvest

McKesson reports Q1 adjusted EPS $8.26, consensus $8.15 - TipRanks

McKesson Well-Positioned to Benefit from GLP-1s and Increasing Presence in Specialty - Morningstar

Mckesson lifts annual profit forecast on robust demand for specialty drugs - MSN

McKesson (MCK) Achieves Record Revenue, Raises Earnings Guidance - GuruFocus

McKesson's Q1 2026: Unraveling Contradictions on Rite Aid, Tariffs, and Market Dynamics - AInvest

McKesson's Strategic Transformation and Earnings Outperformance: A High-Conviction Buy for 2026 - AInvest

McKesson’s (NYSE:MCK) Q2 Sales Top Estimates - Yahoo Finance

Compared to Estimates, McKesson (MCK) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

MCKESSON CORP SEC 10-Q Report - TradingView

Mckesson Lifts Annual Profit Forecast on Robust Demand for Specialty Drugs - Money/ US News

McKesson falls 2.7% despite raising full-year outlook By Investing.com - Investing.com Australia

McKesson Corp Reports Q1 Revenue of $97.8 Billion, Adjusted EPS of $8.26 Surpasses Estimates - GuruFocus

McKesson Q1 2026 slides: Revenue surges 23%, company raises full-year outlook - Investing.com India

McKesson Q1 2026 slides: Revenue surges 23%, company raises full-year outlook By Investing.com - Investing.com South Africa

COR

$294.87

1.32%

CAH

$150.22

1.42%

HSIC

$67.91

1.57%

AHG

$1.74

1.69%

OMI

$5.40

1.31%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters